Down-regulation of WNK1 protein kinase in neural progenitor cells suppresses cell proliferation and migration

Journal of Neurochemistry

Volumn 99, Issue 4, 2006, Pages 1114-1121

  Sun, Xutong ^a   Gao, Luoyi ^a   Yu, Robert K ^a   Zeng, Guichao ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Antisense inhibition; Cell growth; Cell migration; Growth factors; MAP kinase; Neural progenitor cells

Indexed keywords

EPIDERMAL GROWTH FACTOR; MARKER; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGENIC AGENT; PROTEIN KINASE WNK1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CENTRAL NERVOUS SYSTEM; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; MAP KINASE SIGNALING SYSTEM; MICE; NERVE TISSUE PROTEINS; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; STEM CELLS;

EID: 33750484312     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04159.x     Document Type: Article

References (36)

1. Achard J. M., Warnock D. G., Disse-Nicodeme S., Fiquet-Kempf B., Corvol P., Fournier A. and Jeunemaitre X. (2003) Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am. J. Med. 114, 495-498.
2. Bieberich E., Silva J., Wang G., Krishnamurthy K. and Condie B. G. (2004) Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J. Cell Biol. 167, 723-734.
3. Choate K. A., Kahle K. T., Wilson F. H., Nelson-Williams C. and Lifton R. P. (2003) WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl-transporting epithelia. Proc. Natl Acad. Sci. USA 100, 663-668.
4. Cope G., Golbang A. and O'Shaughnessy K. M. (2005) WNK kinases and the control of blood pressure. Pharmacol. Ther. 106, 221-231.
5. Delaloy C., Lu J., Houot A. M., Disse-Nicodeme S., Gasc J. M., Corvol P. and Jeunemaitre X. (2003) Multiple promoters in the WNK1 gene: one controls expression of a kidney-specific kinase-defective isoform. Mol. Cell. Biol. 23, 9208-9221.
6. Doering L. C. and Snyder E. Y. (2000) Cholinergic expression by a neural stem cell line grafted to the adult medial septum/diagonal band complex. J. Neurosci. Res. 61, 597-604.
7. Glass W. F., 2nd, Teng P. R. and Haney L. B. (1996) Extracellular matrix distribution and hillock formation in human mesangial cells in culture without serum. J. Am. Soc. Nephrol. 7, 2230-2243.
8. Hayashi M. and Lee J. D. (2004) Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 82, 800-808.
9. Jiang Z. Y., Zhou Q. L., Holik J., Patel S., Leszyk J., Coleman K., Chouinard M. and Czech M. P. (2005) Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells. J. Biol. Chem. 280, 21 622-21 628.
10. Kitchens D. L., Snyder E. Y. and Gottlieb D. I. (1994) FGF and EGF are mitogens for immortalized neural progenitors. J. Neurobiol. 25, 797-807.
11. Lee B. H., Min X., Heise C. J., Xu B. E., Chen S., Shu H., Luby-Phelps K., Goldsmith E. J. and Cobb M. H. (2004) WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding. Mol. Cell 15, 741-751.
12. Naray-Fejes-Toth A., Snyder P. M. and Fejes-Toth G. (2004) The kidney-specific WNK1 isoform is induced by aldosterone and stimulates epithelial sodium channel-mediated Na+ transport. Proc. Natl Acad. Sci. USA 101, 17 434-17 439.
13. O'Reilly M., Marshall E., Speirs H. J. and Brown R. W. (2003) WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J. Am. Soc. Nephrol. 14, 2447-2456.
14. Ryder E. F., Snyder E. Y. and Cepko C. L. (1990) Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21, 356-375.
15. Snyder E. Y., Deitcher D. L., Walsh C., Arnold-Aldea S., Hartwieg E. A. and Cepko C. L. (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68, 33-51.
16. Snyder E. Y. and Macklis J. D. (1995) Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions. Clin. Neurosci. 3, 310-316.
17. Snyder E. Y. Taylor R. M. and Wolfe J. H. (1995) Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374, 367-370.
18. Snyder E. Y. Yoon C. Flax J. D. and Macklis J. D. (1997) Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl Acad. Sci. USA 94, 11 663-11 668.
19. Taupin P. and Gage F. H. (2002) Adult neurogenesis and neural stem cells of the central nervous system in mammals. J. Neurosci. Res. 69, 745-749.
20. Verissimo F. and Jordan P. (2001) WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20, 5562-5569.
21. Vitari A. C., Deak M., Collins B. J., Morrice N., Prescott A., R. Phelan A., Humphreys S. and Alessi D. R. (2004) WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B) /Akt substrate. Biochem. J. 378, 257-268.
22. Watson F. L., Heerssen H. M., Bhattacharyya A., Klesse L., Lin M. Z. and Segal R. A. (2001) Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat. Neurosci. 4, 981-988.
23. Weiss S. (1999) Pathways for neural stem cell biology and repair. Nat. Biotechnol. 17, 850-851.
24. Wilson F. H., Disse-Nicodeme S., Choate K. A. et al. (2001) Human hypertension caused by mutations in WNK kinases. Science 293, 1107-1112.
25. Wilson F. H., Kahle K. T., Sabath E., Lalioti M. D., Rapson A. K., Hoover R. S., Hebert S. C., Gamba G. and Lifton R. P. (2003) Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc. Natl Acad. Sci. USA 100, 680-684.
26. Xu B., English J. M., Wilsbacher J. L., Stippec S., Goldsmith E. J. and Cobb M. H. (2000) WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J. Biol. Chem. 275, 16 795-16 801.
27. Xu B. E., Lee B. H., Min X., Lenertz L., Heise C. J., Stippec S., Goldsmith E. J. and Cobb M. H. (2005a) WNK1: analysis of protein kinase structure, downstream targets, and potential roles in hypertension. Cell Res. 15, 6-10.
28. Xu B. E., Stippec S., Chu P. Y., Lazrak A., Li X. J., Lee B. H., English J. M., Ortega B., Huang C. L. and Cobb M. H. (2005b) WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc. Natl Acad. Sci. USA 102, 10 315-10 320.
29. c) WNK1 activates SGK1 by a phosphatidylinositol 3-kinase-dependent and non-catalytic mechanism. J. Biol. Chem. 280, 34 218-34 223.
30. Xu B. E., Stippec S., Lenertz L., Lee B. H., Zhang W., Lee Y. K. and Cobb M. H. (2004) WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J. Biol. Chem. 279, 7826-7831.
31. Yang M., Stull N. D., Berk M. A., Snyder E. Y. and Iacovitti L. (2002) Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp. Neurol. 177, 50-60.
32. Zambrowicz B. P., Abuin A., Ramirez-Solis R. et al. (2003) Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc. Natl Acad. Sci. USA 100, 14 109-14 114.
33. Zeng G., Gao L. and Yu R. K. (2000b) Reduced cell migration, tumor growth and experimental metastasis of rat F-11 cells whose expression of GD3-synthase is suppressed. Int. J. Cancer 88, 53-57.
34. Zeng G., Gao L., Birkle S. and Yu R. K. (2000a) Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60, 6670-6676.
35. Zeng G., Gao L., Xia T., Gu Y. and Yu R. K. (2005) Expression of the mouse WNK1 gene in correlation with ganglioside GD3 and functional analysis of the mouse WNK1 promoter. Gene 344, 233-239.
36. Zeng G., Li D. D., Gao L., Birkle S., Bieberich E., Tokuda A. and Yu R. K. (1999) Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression. Biochemistry 38, 8762-8769.